These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 16431252

  • 21. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy.
    Jha V, Ganguli A, Saha TK, Kohli HS, Sud K, Gupta KL, Joshi K, Sakhuja V.
    J Am Soc Nephrol; 2007 Jun; 18(6):1899-904. PubMed ID: 17494881
    [Abstract] [Full Text] [Related]

  • 22. A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy.
    Boumpas DT, Tassiulas IO, Fleisher TA, Vaughan E, Piscitelli S, Kim Y, Pucino F, Balow JE, Austin HA.
    Clin Nephrol; 1999 Aug; 52(2):67-75. PubMed ID: 10480216
    [Abstract] [Full Text] [Related]

  • 23. Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria.
    Li X, Lv R, He Q, Li H, Du X, Lin W, Li Q, He X, Wang S, Chen J.
    J Nephrol; 2008 Aug; 21(4):584-91. PubMed ID: 18651550
    [Abstract] [Full Text] [Related]

  • 24. [Treatment of idiopathic membranous nephropathy].
    Passerini P.
    G Ital Nefrol; 2004 Aug; 21(6):531-9. PubMed ID: 15593020
    [Abstract] [Full Text] [Related]

  • 25. Membranous nephropathy--still a treatment dilemma.
    Cameron JS.
    N Engl J Med; 1992 Aug 27; 327(9):638-9. PubMed ID: 1640957
    [No Abstract] [Full Text] [Related]

  • 26. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
    Busch M, Gerth J, Ott U, Schip A, Haufe CC, Gröne HJ, Wolf G.
    Med Klin (Munich); 2008 Jul 15; 103(7):519-24. PubMed ID: 18604487
    [Abstract] [Full Text] [Related]

  • 27. Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial.
    Hofstra JM, Branten AJ, Wirtz JJ, Noordzij TC, du Buf-Vereijken PW, Wetzels JF.
    Nephrol Dial Transplant; 2010 Jan 15; 25(1):129-36. PubMed ID: 19666912
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of tumour necrosis factor alpha in idiopathic membranous nephropathy: a pilot study.
    Lionaki S, Siamopoulos K, Theodorou I, Papadimitraki E, Bertsias G, Boumpas D, Boletis J.
    Nephrol Dial Transplant; 2009 Jul 15; 24(7):2144-50. PubMed ID: 19202167
    [Abstract] [Full Text] [Related]

  • 29. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
    Alexopoulos E, Papagianni A, Tsamelashvili M, Leontsini M, Memmos D.
    Nephrol Dial Transplant; 2006 Nov 15; 21(11):3127-32. PubMed ID: 16968719
    [Abstract] [Full Text] [Related]

  • 30. [Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis].
    Krasnova TN, Shilov EM, Tareeva IE, Gordovskaia NB, Lavrova ON, Miroshnichenko NG, Troepol'skaia OV, Ivanova LV, Ivanov AA.
    Ter Arkh; 1998 Nov 15; 70(6):14-7. PubMed ID: 9695216
    [Abstract] [Full Text] [Related]

  • 31. The therapy of idiopathic membranous glomerulonephritis.
    Glassock RJ.
    Semin Nephrol; 1991 Mar 15; 11(2):138-47. PubMed ID: 2034923
    [Abstract] [Full Text] [Related]

  • 32. Treatment-related changes in urinary excretion of high and low molecular weight proteins in patients with idiopathic membranous nephropathy and renal insufficiency.
    du Buf-Vereijken PW, Wetzels JF.
    Nephrol Dial Transplant; 2006 Feb 15; 21(2):389-96. PubMed ID: 16234291
    [Abstract] [Full Text] [Related]

  • 33. Effective treatment administration of cyclophosphamide in membranous nephropathy.
    Dede F, Ayili D, Sahiner S.
    J Nephrol; 2008 Feb 15; 21(4):560-5. PubMed ID: 18651546
    [Abstract] [Full Text] [Related]

  • 34. Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial.
    Bomback AS, Canetta PA, Beck LH, Ayalon R, Radhakrishnan J, Appel GB.
    Am J Nephrol; 2012 Feb 15; 36(1):58-67. PubMed ID: 22722778
    [Abstract] [Full Text] [Related]

  • 35. Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide.
    Reichert LJ, Huysmans FT, Assmann K, Koene RA, Wetzels JF.
    Ann Intern Med; 1994 Sep 01; 121(5):328-33. PubMed ID: 8042821
    [Abstract] [Full Text] [Related]

  • 36. A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy.
    Cattran DC, Delmore T, Roscoe J, Cole E, Cardella C, Charron R, Ritchie S.
    N Engl J Med; 1989 Jan 26; 320(4):210-5. PubMed ID: 2643046
    [Abstract] [Full Text] [Related]

  • 37. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
    du Buf-Vereijken PW, Wetzels JF.
    Nephrol Dial Transplant; 2004 Aug 26; 19(8):2036-43. PubMed ID: 15187191
    [Abstract] [Full Text] [Related]

  • 38. Prognosis and management of membraneous nephropathy.
    Pahari DK, Das S, Dutta BN, Banerjee D.
    J Assoc Physicians India; 1993 Jun 26; 41(6):350-1. PubMed ID: 8005970
    [Abstract] [Full Text] [Related]

  • 39. Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults.
    Ponticelli C, Passerini P.
    Clin Nephrol; 1991 Jun 26; 35 Suppl 1():S16-21. PubMed ID: 1860261
    [Abstract] [Full Text] [Related]

  • 40. Application of artificial neural networks in estimating predictive factors and therapeutic efficacy in idiopathic membranous nephropathy.
    Naumovic R, Furuncic D, Jovanovic D, Stosovic M, Basta-Jovanovic G, Lezaic V.
    Biomed Pharmacother; 2010 Nov 26; 64(9):633-8. PubMed ID: 20888177
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.